Market capitalization | $62.22m |
Enterprise Value | $34.88m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.77 |
P/S ratio (TTM) P/S ratio | 3.16 |
P/B ratio (TTM) P/B ratio | 2.31 |
Revenue growth (TTM) Revenue growth | -14.37% |
Revenue (TTM) Revenue | $19.71m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
1 Analyst has issued a forecast Forian Inc.:
1 Analyst has issued a forecast Forian Inc.:
Sep '24 |
+/-
%
|
||
Revenue | 20 20 |
14%
14%
|
|
Gross Profit | 13 13 |
20%
20%
|
|
EBITDA | -5.45 -5.45 |
16%
16%
|
EBIT (Operating Income) EBIT | -5.51 -5.51 |
27%
27%
|
Net Profit | -2.58 -2.58 |
52%
52%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The firm provides a suite of SaaS solution, as well as cannabis dispensaries. The company was founded by Max C. Wygod and Adam Dublin on October 15, 2020 and is headquartered in Newtown, PA.
Head office | United States |
CEO | Max Wygod |
Employees | 37 |
Founded | 2020 |
Website | www.forian.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.